0001628280-25-037141
SEC filingRyan Specialty reported 23.9% total revenue growth to $1.545B driven by acquisitions and 9.6% organic growth, with net income declining 24.2% due to tax items.
For the six months ended June 30, 2025, total revenue increased 23.9% to $1,545.3 million from $1,247.5 million in the prior year period. The growth was driven by $155.7 million from acquisitions in their first twelve months, $114.2 million of organic revenue growth (9.6%), and $28.9 million from higher contingent commissions and foreign exchange, partially offset by a $1.0 million decline in fiduciary investment income. Net commissions and fees grew 24.5% to $1,517.0 million. Operating income rose 22.9% to $291.3 million, with operating margin slightly contracting 1 bps to 18.9% due to increased amortization and G&A costs. Net income decreased 24.2% to $120.3 million, largely attributable to a $48.0 million income tax expense from the common control reorganization (CCR) associated with the Velocity acquisition. Diluted EPS fell to $0.18 from $0.49. On an adjusted basis, Adjusted EBITDAC grew 25.7% to $508.9 million, with margin expanding 40 bps to 32.9%. Adjusted diluted EPS increased 12.9% to $1.05.
All three specialties contributed to revenue growth. Wholesale Brokerage, the largest segment, grew net commissions and fees 9.2% to $837.95 million, driven by organic growth and higher contingent commissions. Binding Authorities increased 16.1% to $196.47 million on strong organic performance and contingent commissions. Underwriting Management posted the strongest growth at 71.5% to $482.56 million, reflecting organic gains and contributions from recent acquisitions (Castel, US Assure, Greenhill, Ethos P&C, EverSports, Geo, Innovisk, Velocity, 360, and USQ). The segment mix shifted heavily toward Underwriting Management, which represented 31.8% of total net commissions and fees versus 23.1% a year ago.
Management expects continued investment in operations and technology, with growth driven by deepening retail broker relationships, expanding delegated authority business, and pursuing strategic M&A. They note that property premium rate declines may persist through the end of 2025, impacting the property portfolio, but overall E&S market fundamentals remain supportive. No specific numeric guidance was provided. The company completed three acquisitions in early 2025 and one additional after quarter-end, signaling ongoing inorganic expansion. Adjusted EBITDAC margin improvement is expected from scale benefits as revenue grows.
Cash and cash equivalents stood at $172.6M as of June 30, 2025, down from $540.2M at year-end 2024, primarily used for acquisitions. Total debt increased to $3.47B from $3.28B, reflecting net borrowings of $189.2M. The revolving credit facility had $1.22B available after draws of $184.1M. Shareholders' equity grew to $1.18B from $1.10B, supported by retained earnings and other comprehensive income.
The Notes disclose contingent consideration liabilities of $114.6M and contingently returnable consideration of $5.3M, related to earnouts from acquisitions. Legal contingencies include $7.2M for E&O matters and $0.7M for replacement costs from a trading partner issue. No material purchase commitments (e.g., supply agreements) were reported.
No share repurchase activity or authorization was disclosed. Dividends: $0.12 per share quarterly, totaling $30.2M paid in H1 2025. Debt changes: $680.5M drawn on revolver, $492.8M repaid, plus $8.5M term loan repayment. Net debt increase funded the Velocity ($548.6M) and other acquisitions. Capital expenditures were $36.5M (2.4% of revenue), up from $22.6M in the prior year period.
Ryan Specialty operates as a single segment, but revenue is disaggregated by specialty: Wholesale Brokerage ($838.0M, +9.2%), Binding Authority ($196.5M, +16.1%), and Underwriting Management ($482.6M, +71.5% driven by acquisitions). Geographically, U.S. revenue accounted for $1.45B (94%) and foreign $94.7M (6%). No segment operating income is disclosed in the Notes.
Operating cash flow (CFO) of $210.8M exceeded net income of $120.3M, indicating strong cash generation despite lower earnings. The divergence is largely due to non-cash charges: amortization ($134.7M), equity-based compensation ($39.8M), and deferred tax expenses ($57.5M including common control reorganization). Working capital was a net use of cash ($168.9M), primarily from an increase in commissions and fees receivable ($98.4M) and a decrease in accrued liabilities ($117.0M), partly offset by other asset reductions.
Capital expenditures rose 61.7% to $36.5M, reflecting investment in infrastructure. Investing outflows were dominated by $565.1M in business combinations. Financing activities provided $234.4M, driven by net borrowings on the revolving credit facility ($187.7M) and a net increase in fiduciary liabilities ($166.3M), partially offset by dividends of $30.5M and distributions to non-controlling interests ($13.6M).
Anomalies include a $48.0M deferred tax expense from a common control reorganization and a $47.8M equity method investment in VSIC. The large investing outflows were funded by debt and fiduciary cash flows, while the overall net change in cash was -$162.0M.